AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $134,000 | -11.3% | 17,920 | +8.0% | 0.00% | – |
| Q1 2022 | $151,000 | +28.0% | 16,600 | -1.1% | 0.00% | – |
| Q4 2021 | $118,000 | -94.8% | 16,791 | -91.6% | 0.00% | -100.0% |
| Q3 2021 | $2,289,000 | -32.3% | 200,823 | -4.9% | 0.01% | -28.6% |
| Q2 2021 | $3,380,000 | -13.1% | 211,164 | -3.0% | 0.01% | -12.5% |
| Q1 2021 | $3,890,000 | -57.2% | 217,738 | -67.7% | 0.01% | -55.6% |
| Q4 2020 | $9,095,000 | +28.5% | 673,268 | +12.0% | 0.02% | +12.5% |
| Q3 2020 | $7,078,000 | -18.6% | 601,361 | +2.0% | 0.02% | -20.0% |
| Q2 2020 | $8,699,000 | +4.7% | 589,321 | -4.2% | 0.02% | -9.1% |
| Q1 2020 | $8,305,000 | -44.5% | 615,202 | -0.6% | 0.02% | -29.0% |
| Q4 2019 | $14,962,000 | +7.1% | 619,026 | -14.8% | 0.03% | 0.0% |
| Q3 2019 | $13,967,000 | +2.7% | 726,702 | +57.8% | 0.03% | +6.9% |
| Q2 2019 | $13,605,000 | -35.6% | 460,406 | +3.5% | 0.03% | -38.3% |
| Q1 2019 | $21,122,000 | +17.3% | 444,688 | -10.9% | 0.05% | +6.8% |
| Q4 2018 | $18,012,000 | -29.8% | 498,952 | +19.6% | 0.04% | -17.0% |
| Q3 2018 | $25,670,000 | -1.5% | 417,060 | +8.1% | 0.05% | -3.6% |
| Q2 2018 | $26,054,000 | +5.5% | 385,693 | -15.3% | 0.06% | +3.8% |
| Q1 2018 | $24,707,000 | +3.9% | 455,450 | +14.5% | 0.05% | +8.2% |
| Q4 2017 | $23,777,000 | -2.5% | 397,928 | -20.7% | 0.05% | -5.8% |
| Q3 2017 | $24,385,000 | +31.5% | 501,741 | +42.2% | 0.05% | +26.8% |
| Q2 2017 | $18,538,000 | +45.6% | 352,776 | +25.7% | 0.04% | +41.4% |
| Q1 2017 | $12,730,000 | +20.6% | 280,710 | +0.6% | 0.03% | +16.0% |
| Q4 2016 | $10,559,000 | +2533.2% | 278,958 | +2523.8% | 0.02% | +2400.0% |
| Q3 2016 | $401,000 | +114.4% | 10,632 | 0.0% | 0.00% | – |
| Q2 2016 | $187,000 | -95.7% | 10,632 | -94.1% | 0.00% | -100.0% |
| Q4 2015 | $4,372,000 | -13.2% | 179,548 | -36.8% | 0.01% | -15.4% |
| Q3 2015 | $5,038,000 | -27.0% | 283,973 | -27.4% | 0.01% | -18.8% |
| Q2 2015 | $6,900,000 | +14.2% | 390,940 | +102.7% | 0.02% | +23.1% |
| Q1 2015 | $6,044,000 | – | 192,847 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |